Piper Sandler Downgrades Acceleron Pharma (XLRN) to Neutral

September 30, 2021 9:19 AM EDT
Get Alerts XLRN Hot Sheet
Price: $178.75 --0%

Rating Summary:
    11 Buy, 11 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 2 | Down: 23 | New: 24
Join SI Premium – FREE

Piper Sandler analyst Danielle Brill downgraded Acceleron Pharma (NASDAQ: XLRN) from Overweight to Neutral with a price target of $180.00.

For an analyst ratings summary and ratings history on Acceleron Pharma click here. For more ratings news on Acceleron Pharma click here.

Shares of Acceleron Pharma closed at $175.36 yesterday.

You May Also Be Interested In

Related Categories